TRAX - First Tracks Biotherapeutics, Inc

First Tracks Biotherapeutics, Inc (TRAX)

NGS · Common · CUSIP 337185102

Last Price•••.••

Current Yield•.••%

Yield to Call•.••%

Yield to Worst•.••%

Free registration unlocks the quote, yield calculations, price chart and full fundamentals for TRAX and every other security on QuantumOnline.

Overview Financials 🔒 Earnings 🔒 Dividends 🔒 Analysts 🔒 Ownership 🔒 ESG 🔒 Technicals 🔒

🔒

Price chart and 15 days of daily prices

Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type: Common Stock
CUSIP: 337185102

Links: Home Page Investor Relations News

Business: First Tracks Biotherapeutics, Inc is a clinical stage biotechnology company advancing antibody therapies that modulate immune pathways implicated in autoimmune and inflammatory diseases.

Company Contact

CEO: Daniel Faga
CFO: Ajim Tamboli
Headquarters: 10770 Wateridge Circle, Suite 210, San Diego, CA 92121
Phone: 858-362-6295
Email Form: Contact Form »
SEC EDGAR Filings: View filings »